22 Jan 2019 | 2:58 PM
 

Strides Pharma Science Ltd. Share Price Live (BSE)
0

BSE Code: 532531 | NSE Symbol: STAR
541.65
27.00
(5.25 %)
22 Jan 2019 | 02:46 PM
Change company
  • Open (Rs)
    512.96
  • Prev. close (Rs.)
    514.65
  • High (Rs.)
    547.00
  • Low (Rs.)
    508.65
  • 52W H (Rs.)
    827.05
  • 52W L (Rs.)
    334.10
  • Volume
    168362
  • MCap (Rs in Cr.)
    4,850.43
545.25
29.35
(5.69 %)
  • Open (Rs)
    513.10
  • High (Rs)
    548.50
  • Low (Rs)
    510.00
  • Prev. close(Rs)
    515.90
  • Contracts Tra.
    35,18,900
  • Turnover (Cr.)
    187
  • Open Interest
    43,26,300
  • Open Int. chg
    4,21,300.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
73.80
Operating Margin (%)
13.96
Gross Profit Margin (%)
8.54
Net Profit Margin (%)
23.26
Total Debt/Equity
1.02
Dividend payout Ratio (Net Profit)
7.38
Earning Retention Ratio
62.64

News

09 Nov 2018 - 12:28:00-Strides Pharma Science Friday said its step-down subsidiary has entered into an exclusive product de...
31 Oct 2018 - 15:54:00-Drug firm Strides Pharma Science Wednesday said it has partnered with funds advised by ICP-III Inves...
18 Sep 2018 - 16:31:00-Drug firm Strides Pharma Science Tuesday said the US health regulator has issued three observations ...
07 Sep 2018 - 00:11:00-Strides Pharma Science`s promoter Abusha Investment & Management Services LLP sold 4 lakh shares of ...

Announcements

22-Jan-2019
Strides Pharma Scien - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone
19-Jan-2019
Strides Pharma Scien - Shareholding for the Period Ended December 31 2018
24-Dec-2018
Strides gets USFDA nod for Polyethylene Glycol 3350 and Electrolytes for oral solution
24-Dec-2018
Strides Pharma Scien - Press Release
24-Dec-2018
Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Religare Research

21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...
04 Jan 2019 | 09:57 AM
The rupee settled at 70.19 to a dollar, its lowest since Dec. 27, against 70.17 at previous close. I...
03 Jan 2019 | 09:56 AM
The rupee settled at 70.17 to a dollar, its lowest since Dec. 27, against 69.45 at previous close. T...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
16,99,963 148.36 176.34 -0.54
16,99,963 148.36 61.39 -0.54
16,99,963 148.36 1,059.25 -0.54
16,99,963 148.36 557.73 -0.54
16,99,963 148.36 1,105.45 -0.53

Shareholding Pattern

       
Promotors30.79%
Mutual Funds/UTI24.51%
FI/Banks1.15%
Insurance1.15%
FII21.96%
Government0.00%
Others7.48%

Peer Group

Company Intraday Graph
 Merck Ltd.
3,334.55(1.05)
3302
 AstraZeneca Pharma India Ltd.
1,610.00(0.23)
3274
 Dr. Lal Pathlabs Ltd.
1,033.60(1.50)
17140
 Ipca Laboratories Ltd.
770.20(-1.02)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Strides Pharma Science Ltd.81.65120.70179.80
NIFTY(S&P CNX)141.05649.80-189.70
BSE SENSEX637.582,245.27-338.95
BSE 50043.98842.32-410.04

Corporate Details

Key Personal
Arun Kumar
Managing Director & Group CEO
Badree Komandur
Executive Director - Finance
Deepak Vaidya
Chairperson
Key Address
Registered Office
201 Devavrata Sector 17 Vashi,New Mumbai,Maharashtra

Tel:022-27893199, Fax:022-27892942

info@strides.com
http://www.strides.com
Registrar Office
Karvy Fintech Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda